Adam Maeder
Stock Analyst at Piper Sandler
(4.59)
# 927
Out of 4,491 analysts
350
Total ratings
54.7%
Success rate
12.1%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintained: Hold | $10 | $5.62 | +77.94% | 9 | Jul 7, 2026 | |
| GKOS Glaukos | Reiterated: Buy | $165 | $150.65 | +9.53% | 16 | Jul 1, 2026 | |
| LIVN LivaNova | Maintained: Buy | $85 → $87 | $83.58 | +4.09% | 33 | Jun 23, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $115 | $95.84 | +19.99% | 18 | Jun 22, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $580 | $427.30 | +35.74% | 49 | Jun 2, 2026 | |
| STAA STAAR Surgical Company | Maintained: Hold | $16 → $33 | $26.55 | +24.29% | 5 | May 14, 2026 | |
| STXS Stereotaxis | Reiterated: Buy | $4 → $3.5 | $1.82 | +92.31% | 18 | May 13, 2026 | |
| NYXH Nyxoah | Reiterated: Buy | $9 → $7 | $1.68 | +316.67% | 24 | May 13, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $9 | $5.35 | +68.22% | 8 | May 7, 2026 | |
| RMD ResMed | Maintained: Hold | $275 → $233 | $219.75 | +6.03% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $94.82 | +5.46% | 55 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $31.49 | +33.38% | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $85 → $55 | $50.08 | +9.82% | 49 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 → $3 | $1.55 | +93.55% | 13 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.5 → $7 | $0.15775 | +4,337.40% | 12 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.7178 | +457.26% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $45.55 | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.55 → $2.13 | $0.215 | n/a | 2 | Dec 23, 2019 |
RxSight
Jul 7, 2026
Maintained: Hold
Price Target: $10
Current: $5.62
Upside: +77.94%
Glaukos
Jul 1, 2026
Reiterated: Buy
Price Target: $165
Current: $150.65
Upside: +9.53%
LivaNova
Jun 23, 2026
Maintained: Buy
Price Target: $85 → $87
Current: $83.58
Upside: +4.09%
Abbott Laboratories
Jun 22, 2026
Reiterated: Buy
Price Target: $115
Current: $95.84
Upside: +19.99%
Intuitive Surgical
Jun 2, 2026
Reiterated: Buy
Price Target: $580
Current: $427.30
Upside: +35.74%
STAAR Surgical Company
May 14, 2026
Maintained: Hold
Price Target: $16 → $33
Current: $26.55
Upside: +24.29%
Stereotaxis
May 13, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $1.82
Upside: +92.31%
Nyxoah
May 13, 2026
Reiterated: Buy
Price Target: $9 → $7
Current: $1.68
Upside: +316.67%
Sight Sciences
May 7, 2026
Reiterated: Buy
Price Target: $9
Current: $5.35
Upside: +68.22%
ResMed
May 6, 2026
Maintained: Hold
Price Target: $275 → $233
Current: $219.75
Upside: +6.03%
May 5, 2026
Maintained: Buy
Price Target: $100
Current: $94.82
Upside: +5.46%
May 5, 2026
Reiterated: Buy
Price Target: $42
Current: $31.49
Upside: +33.38%
May 5, 2026
Downgraded: Hold
Price Target: $85 → $55
Current: $50.08
Upside: +9.82%
Apr 7, 2026
Maintained: Buy
Price Target: $5.5 → $3
Current: $1.55
Upside: +93.55%
Aug 13, 2025
Maintained: Hold
Price Target: $8.5 → $7
Current: $0.15775
Upside: +4,337.40%
Aug 1, 2025
Maintained: Buy
Price Target: $4
Current: $0.7178
Upside: +457.26%
Apr 9, 2020
Initiated Coverage: Buy
Price Target: $74
Current: $45.55
Upside: n/a
Dec 23, 2019
Reiterated: Buy
Price Target: $3.55 → $2.13
Current: $0.215
Upside: n/a